An experimental blood clot-removing device outperformed the FDA-approved MERCI; retriever device, according to late-breaking science presented at the American Stroke Association's 2012 International Stroke Conference.

University of Rochester Medical Center researchers have discovered new links between leukaemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer progresses and raising the possibility that therapies for bone disorders could help in the treatment of leukaemia.

Drinking a cup of black tea three times a day may significantly reduce your blood pressure. In a world first, scientists at The University of Western Australia and Unilever discovered that black tea lowers systolic and diastolic blood pressure.* Their research is published in the Archives of Internal Medicine.

Researchers have developed a bandage that stimulates and directs blood vessel growth on the surface of a wound. The bandage, called a "microvascular stamp," contains living cells that deliver growth factors to damaged tissues in a defined pattern. After a week, the pattern of the stamp "is written in blood vessels," the researchers report.

People with low levels of iron in the blood have a higher risk of dangerous blood clots, according to research published in the journal Thorax on Dec 15. A study of clotting risk factors in patients with an inherited blood vessel disease suggests that treating iron deficiency might be important for preventing potentially lethal blood clots.

Statins, traditionally known as cholesterol-lowering drugs, may reduce mortality among patients hospitalised with influenza, according to a new study released online by The Journal of Infectious Diseases.

A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I clinical trial led by Dana-Farber Cancer Institute scientists indicates.

Cancer of the liver – rare in the United States but the third-leading cause of cancer death worldwide – can result from environmental exposures or infections like chronic hepatitis, but the link is poorly understood.

Groundbreaking research from the Queensland Institute of Medical Research is set to pave the way for the development of new malaria drugs and vaccines.

An oral anti-clotting drug, when added to standard medical treatment for acute coronary syndrome, lowered the risk of death, heart attack or stroke an average of 16 percent, according to research presented at the American Heart Association's Scientific Sessions.